162 results
8-K
EX-10.2
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
of the transactions contemplated hereby. The Investor and each Account has had access to the Company filings with the Securities and Exchange Commission
8-K
EX-4.1
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
Repurchase Notice
Attachment 3
Form of Assignment and Transfer
Attachment 4
Form of Asset Sale Repurchase Notice
Attachment 5
Platform Access Request
vi … Venture” to which such Person is a party.
“Landlord Collateral Access Agreement” means a Landlord Waiver and Consent Agreement substantially in the form
8-K
EX-10.3
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
party, on the one hand, or by the Indemnified Person or Indemnified Party, on the other hand, and the parties’ relative intent, knowledge, access
8-K
EX-10.4
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
investigation and appraisal of the transactions contemplated hereby. 2029 Convertible Note Investor has had access to the Company filings with the SEC
8-K
EX-10.1
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
Certificate
E-4
U.S. Tax Compliance Certificate
F-1
Closing Date Certificate
F-2
Solvency Certificate
Counterpart Agreement
Landlord Collateral Access … Deposit Account Control Agreements, any Securities Account Control Agreements, any Landlord Collateral Access Agreements, the Intercreditor Agreement
8-K
EX-99.1
box47i3s787zb
8 May 24
Entry into a Material Definitive Agreement
7:52am
8-K
EX-99.1
1z8r az3hc
8 May 24
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
7:47am
DEFA14A
pmtlcc82ls8z0f
19 Apr 24
Additional proxy soliciting materials
7:44am
8-K
EX-99.1
wn5v0i2b70b8 g5x
29 Feb 24
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
7:35am
8-K
EX-99.1
fjmp5l
2 Nov 23
Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am
8-K
EX-99.1
2v5mh0xrmc y1z
2 Aug 23
Karyopharm Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am
8-K
EX-99.1
l4ar9519swtzc4e
4 May 23
Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
7:53am
DEFA14A
6bvt6tru qqo781se
11 Apr 23
Additional proxy soliciting materials
8:11am